Indonesia Should Reject New IP Monopoly Protections for Medicines

“The status quo of rich countries imposing ever increasing monopoly protections to benefit the market control and profiteering of their transnational pharmaceutical giants must end,” writes Professor Brook Baker ’76, senior policy analyst for HealthGAP, in an opinion piece for The Jakarta Post.